Can caffeine metabolism be used as an in-vivo probe for human flavin-containing monooxygenase activity?
- 1 April 2000
- journal article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 10 (3) , 275-277
- https://doi.org/10.1097/00008571-200004000-00010
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP 1A2 and flavin-containing monooxygenase in N-demethylation of caffeine: identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patternsChemico-Biological Interactions, 1998
- Oxidation of Caffeine to Theobromine and Theophylline Is Catalyzed Primarily by Flavin-Containing Monooxygenase in Liver MicrosomesBiochemical and Biophysical Research Communications, 1997
- The use of caffeine as a metabolic probe for human drug metabolizing enzymesGeneral Pharmacology: The Vascular System, 1996
- Caffeine as a metabolic probe: a comparison of the metabolic ratios used to assess CYP1A2 activity.British Journal of Clinical Pharmacology, 1995
- Porphyrin π-cation and protein radicals in peroxidase catalysis and inhibition by anti-thyroid chemicalsXenobiotica, 1995
- Placental peroxidase—Further purification of the enzyme and oxidation of thiobenzamidePlacenta, 1993
- The use of caffeine for enzyme assays: A critical appraisalClinical Pharmacology & Therapeutics, 1993
- Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolitesPharmacogenetics, 1992
- Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1Pharmacogenetics, 1992
- Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activitiesClinical Pharmacology & Therapeutics, 1991